Brianna L Norton (Briana L Norton)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Antiretroviral Therapy

Alcohol Consumption

Hepatitis C Virus

Top Venues

Journal of viral hepatitis

Open forum infectious diseases

Journal of medical Internet research

This page only lists publications with an associated author ORCID identifier.

Publications

Alison Karasz, Krupa Merchant, Julia H Arnsten, Judith Feinberg, Arthur Y Kim, Paula J Lum, Melissa Diane McKee, Shruti H Mehta, Paul Meissner, Brianna L Norton, Kimberly Page, Irene Pericot-Valverde, Reena Singh, Ellen Stein, Lynn E Taylor, Judith I Tsui, Katherine Wagner, Alain H Litwin
A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences. Journal of medical Internet research 25 (2023)
Madhuri Martin, Prerana J Roth, Jiajing Niu, Irene Pericot-Valverde, Moonseong Heo, Akhila Padi, Brianna L Norton, Matthew J Akiyama, Alain H Litwin
Changes in alcohol use during hepatitis C treatment in persons who inject drugs. Journal of viral hepatitis 29 (11) (2022)
Moonseong Heo, Irene Pericot-Valverde, Jiajing Niu, Brianna L Norton, Matthew J Akiyama, Shadi Nahvi, Julia H Arnsten, Alain H Litwin
More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study. Journal of viral hepatitis (2022)
Irene Pericot-Valverde, Lior Rennert, Moonseong Heo, Matthew J Akiyama, Brianna L Norton, Linda Agyemang, Brandon Lumsden, Alain H Litwin
Rates of perfect self-reported adherence to direct-acting antiviral therapy and its correlates among people who inject drugs on medications for opioid use disorder: The PREVAIL study. Journal of viral hepatitis 28 (3) (2020)
Brianna L Norton, Matthew J Akiyama, Linda Agyemang, Moonseong Heo, Irene- Pericot-Valverde, Alain H Litwin
Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents. Open forum infectious diseases 7 (10) (2020)